Current Research in Immunology (Jan 2021)

Plasmodium berghei Hsp90 contains a natural immunogenic I-Ab-restricted antigen common to rodent and human Plasmodium species

  • Matthias H. Enders,
  • Ganchimeg Bayarsaikhan,
  • Sonia Ghilas,
  • Yu Cheng Chua,
  • Rose May,
  • Maria N. de Menezes,
  • Zhengyu Ge,
  • Peck Szee Tan,
  • Anton Cozijnsen,
  • Vanessa Mollard,
  • Katsuyuki Yui,
  • Geoffrey I. McFadden,
  • Mireille H. Lahoud,
  • Irina Caminschi,
  • Anthony W. Purcell,
  • Ralf B. Schittenhelm,
  • Lynette Beattie,
  • William R. Heath,
  • Daniel Fernandez-Ruiz

Journal volume & issue
Vol. 2
pp. 79 – 92

Abstract

Read online

Thorough understanding of the role of CD4 T cells in immunity can be greatly assisted by the study of responses to defined specificities. This requires knowledge of Plasmodium-derived immunogenic epitopes, of which only a few have been identified, especially for the mouse C57BL/6 background. We recently developed a TCR transgenic mouse line, termed PbT-II, that produces CD4+ T cells specific for an MHC class II (I-Ab)-restricted Plasmodium epitope and is responsive to both sporozoites and blood-stage P. berghei. Here, we identify a peptide within the P. berghei heat shock protein 90 as the cognate epitope recognised by PbT-II cells. We show that C57BL/6 mice infected with P. berghei blood-stage induce an endogenous CD4 T cell response specific for this epitope, indicating cells of similar specificity to PbT-II cells are present in the naïve repertoire. Adoptive transfer of in vitro activated TH1-, or particularly TH2-polarised PbT-II cells improved control of P. berghei parasitemia in C57BL/6 mice and drastically reduced the onset of experimental cerebral malaria. Our results identify a versatile, potentially protective MHC-II restricted epitope useful for exploration of CD4 T cell-mediated immunity and vaccination strategies against malaria.

Keywords